A Study With Mirabegron 50 mg and 25 mg in Chinese Participants With Overactive Bladder
Status:
Recruiting
Trial end date:
2022-06-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of mirabegron for the treatment of
overactive blsdder (OAB) in Chinese participants. This study will also evaluate the safety of
mirabegron for the treatment of OAB in Chinese participants, evaluate other efficacy
variables of mirabegron for the treatment of OAB and explore different mirabegron starting
doses.